<DOC>
	<DOCNO>NCT03095625</DOCNO>
	<brief_summary>Coagulation dysfunction frequent septic patient associated increase risk mortality . During sepsis platelet number usually decrease function reduce mechanism sustain inflammatory induce coagulopathy . Some recent study evaluate possibility use viscoelastic whole blood test haemostasis , thromboelastography ( TEG ) , analyze blood component interaction clot formation dissolution might useful assess bleed risk septic patient . Maximun amplitude ( MA ) one variable obtain TEG analysis express strength clot efficacy platelet function . A low level MA describe low strength clot determine low number reduce function platelet . The aim present study evaluate whether low level MA pattern hypocoagulability might associate increase risk bleed need transfusion patient sepsis . We want conduct prospective multicenter observational study , enrol 100 consecutive adult patient sepsis . We exclude patient 18 year old age , chronic use oral anticoagulant anti platelet treatment , hematologic malignancy , congenital bleeding disorder , oral contraceptive , lack consent . Primary end point To evaluate whether low level MA might associate increase risk bleeding . Secondary end point : evaluate whether different level MA correlate biomarker severity sepsis presepsin , biomarker severity infection whether pattern hypocoagulability might associate risk mortality . All enrol patient undergo blood sample admission ( T0 ) , 72 hour ( T1 ) 7 day ( T2 ) follow parameter measure : Platelet count , APTT , PT , INR , fibrinogen , procalcitonin presepsin . Additionally , viscoelastic parameter ( reaction time ( R ) , clot formation speed ( K ) , angle ( alpha ) maximum amplitude ( MA ) ) perform bedside , T0 , T1 , T2 : Outcome measurement : Intensive Care Unit Length Stay mortality 28 day 90 day .</brief_summary>
	<brief_title>Role Thromboelastography Septic Shock</brief_title>
	<detailed_description>Introduction Coagulation dysfunction frequent patient severe sepsis associate increase risk mortality . During sepsis platelet number usually decrease function reduce mechanism sustain inflammatory induce coagulopathy . Several study show correlation alter function platelet sepsis severity . Conventional coagulation test activate partial thromboplastin time ( APTT ) , prothrombin time ( PT ) international normalize ratio ( INR ) develop mainly monitor anticoagulation treatment may fully reflect complex vivo coagulation disturbance usually characterize sepsis . More recently study evaluate possibility use viscoelastic whole blood test haemostasis , thromboelastography ( TEG ) thromboelastometry ( ROTEM ) , analyze blood component interaction clot formation dissolution might useful assess bleed risk septic patient . A recent study identify possible hypocoagulability pattern among septic patient risk bleed use TEG variable author find strong correlation increase risk death . Maximun amplitude ( MA ) one variable obtain TEG analysis express strength clot efficacy platelet function . A low level MA describe low strength clot determine low number reduce function platelet . In one recent study describe low MA describe hypocoagulability pattern might associate increased risk death . The aim present study evaluate whether low level MA pattern hypocoagulability might associate increase risk bleed need transfusion patient sepsis . Methods A prospective multicenter observational study conduct five intensive care unit five Italian university hospital . We ask Ethic Committee approval . Inclusion criterion : : adult patient diagnosis sepsis admit 48 hour enrol . Exclusion criterion : patient young 18 year old age ; chronic use oral anticoagulant anti platelet treatment ; hematologic malignancy ; congenital bleeding disorder ; oral contraceptive ; lack consent . Primary end point To evaluate whether low level MA might associate increase risk bleeding . Secondary end point 1 . To evaluate whether different level MA correlate biomarker severity sepsis presepsin ( PSEP ) . 2 . To evaluate whether different level MA correlate biomarker severity infection procalcitonin ( PCT ) . 3 . To evaluate whether pattern hypocoagulability might associate risk mortality . Study Design Prospective , multicenter , observational All demographic clinical data collect patient , follow : Age , gender , weight , simplify acute physiology score ( SAPS ) II , sequential organ failure assessment ( SOFA ) score ( admission every 72 hour ) , clinical pulmonary infection score ( CPIS ) , source infection come lung , type infection microbiological isolation , haemodynamic parameter ( heart rate , mean arterial pressure , pulmonary capillary wedge pressure , cardiac output , mixed venous oxygen saturation ) renal function ( creatinine , urine output fluid balance ) . All enrol patient undergo blood sample admission ( T0 ) , 72 hour ( T1 ) 7 day ( T2 ) follow parameter measure : Platelet count , APTT , PT , INR , fibrinogen , procalcitonin presepsin . Additionally , viscoelastic parameter perform bedside , use TEG 5000 Hemostasis Analyzer System ( Haemoscope Corporation , Chicago , Illinois , USA ) , T0 , T1 , T2 : 1. reaction time ( R ) , normal range ( 3-8 sec ) 2. clot formation speed ( K ) , normal range ( 1-3 sec ) 3. angle ( alpha ) , reflect clot growth kinetics , normal range ( 55-75Â° ) 4. maximun amplitude ( MA ) , normal range ( 51-69 mm ) 5. fibrinogen maximun amplitude ( FFMA ) , normal range ( 14-24 mm ) Bleeding definition We define bleed event intracranial bleeding identify CT scan bleed gastrointestinal tract ( hematemesis melena frank blood stool ) , tracheal aspirate urine bleed surgery wound bleed event require concomitant transfusion three unit red blood cell . Outcome measurements 1 . Intensive Care Unit Length Stay ( ICU-LOS ) ; 2 . Mortality 28 day 90 day . Statistical analysis A power analysis calculate consider primary endpoint : correlation level MA risk bleeding . We define bleed intracranial , gastrointestinal , tracheal surgical bleeding bleed event require concomitant transfusion three unit red blood cell . From previous study observe incidence 26 % . Power 86.4 % B ( size regression coefficient ) 0.1 Standard deviation MA 6 P ( event rate ) 26 % Alpha 0.05 The expected number patient enrol 24 month 100 Cox proportional hazard model estimate Hazard Ratios ( HR ) 95 % CI parameter follow table . A Cox regression log hazard ratio MA covariate standard deviation 6 , base sample 100 observation achieve 86.4 % power 0.05 significance level detect regression coefficient equal 0.1 ( log hazard ratio ) . The sample size adjust bleed rate 26 % . The characteristic patient clinical measure describe use appropriate statistic , mean ( SD ) , median ( IQR ) percentages accord variable type distribution . The cumulative incidence bleed period observation ( 7 day ) estimate Gooley method , take account competitive risk death , compare Gray test . The Fine Grey model use estimate adjust HR 95 % CI . Evaluation association MA severity disease infection assess use Spearman 's correlation test .</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>adult patient diagnosis sepsis admit 48 hour enrol patient young 18 year old age ; chronic use oral anticoagulant anti platelet treatment ; hematologic malignancy ; congenital bleeding disorder ; oral contraceptive ; lack consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Bleeding disorder</keyword>
	<keyword>Viscoelastic test</keyword>
</DOC>